GPC3 and neoplasm: Histopathological confirmation was obtained via liver biopsy or surgical specimen, with immunohistochemistry performed to assess tumor differentiation using markers such as CK7, CK19, CK20, CK AE1/AE3, glypican-3, TTF-1, and CD34.